Using Genetic Profiles to Predict Medication Response in Bipolar Disorder
This month’s edition of Discovery’s Edge, Mayo Clinic’s Online Research Magazine, features an article entitled “The Genomics of Bipolar Disorder.” The article looks at biobanking – a practice in which research centers store a lot of information on thousands of people with certain disorders, in this case bipolar. Mayo Clinic, in conjunction with several other research centers, is collecting blood samples and clinical information from 2,000 patients. This information is stored anonymously, and researchers can use this high volume of data to look at specific questions about bipolar disorder.
The primary focus of this work is related to genomics – looking at genetic associations to bipolar disorder. The work is not just about which genes and genetic variations contribute to causing bipolar disorder, but also examines subtypes of bipolar disorder and patterns of medication response. Partly due to genetic differences, people experience different benefits and side effects to the same medications.


Whenever I attend a mental health support group meeting, I’m reminded of how important it is to talk about what we’re dealing with. I’m also reminded of how difficult the subject of mental illness can be to discuss in our usual social circles, sometimes even with close friends and family members. Stigma-induced fear and shame often silence us, causing us to suffer needlessly in isolation. In a support group, you can open up, release some of that emotional pressure, and lighten your load.
A recent study published in the Journal of Clinical Psychiatry entitled “Are Mood Disorders and Obesity Related? A Review for the Mental Health Professional” (McElroy, Susan L.; Kotwal, Renu; Malhotra, Shishuka; Nelson, Erik B.; Keck, Paul E., Jr.; Nemeroff, Charles B.) reveals a possible connection between obesity and mood disorders including major depressive disorder and bipolar disorder. 
If brain chemistry can affect thoughts and behaviors, can thoughts and behaviors affect brain chemistry and perhaps even rewire the brain?
I recently attended a NAMI (National Alliance on Mental Illness) support group meeting that’s run as a problem-solving workshop. All attendees are sworn to confidentiality, so I won’t go into details, but as one of the attendees described her situation, I felt overwhelmed by what she perceived to be the problem. It was total chaos. What she described as one problem was actually a problem pileup – numerous problems all jammed together.
This past weekend, I participated in NAMI’s Family-to-Family training program to become a facilitator (presenter) for the course. My goal is to work with others to start a NAMI (National Alliance on Mental Illness) affiliate and one or more mental health support groups in Crawfordsville, Indiana, and offer the Family-to-Family course to people in the area who have a loved one living with a “persistent and serious mental illness” – bipolar disorder (manic depression), schizophrenia, major depressive disorder, panic and other anxiety disorders including obsessive compulsive disorder (OCD), post traumatic stress disorder (PTSD), or borderline personality disorder (BPD).